NetworkNewsBreaks

WednesdaySep 23, 2020 9:45 am

NetworkNewsBreaks – Predictive Oncology (NASDAQ: POAI) Granted License for Additional 71 Unique Ovarian Cancer Cell Lines

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has announced that TumorGenesis, a division of the company, has received a license for an additional 71 unique ovarian cancer call lines. The licensing comes from England-based Ximbio, the largest nonprofit in the world dedicated to life science reagents. TumorGenesis now has a total of 96 unique patient-derived ovarian cancer cell lines. Research such as that conducted by TumorGenesis is  the foundation of preclinical research and development. “It is remarkable that the UK cancer researchers using the same media mixes now…

Continue Reading

TuesdaySep 22, 2020 5:03 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP), Sub-Licensee Partner Advancing Lead Drug Candidate in First-Ever Phase 1 and Phase 2 Clinical Trials

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, is advancing its leading drug candidate, Berubicin, to move forward with clinical trials in Poland. This move comes after sub-licensee WPD Pharmaceuticals Inc. has identified a contract research organization — Worldwide Clinical Trials — to coordinate and supervise Phase 1 and Phase 2 trials in the European country (http://nnw.fm/zOId7). A recent article discussing this reads, “Berubicin is proposed for the treatment of glioblastoma multiforme (‘GBM’), an aggressive and incurable form of brain cancer. Berubicin…

Continue Reading

TuesdaySep 22, 2020 4:14 pm

NetworkNewsBreaks – Mobius Interactive Ltd. CEO ‘Betting on the Growth of eSports’

Mobius Interactive’s CEO Lynn Pearce authored the feature article, “The Rise of eSports,” in the most recent issue of “Infinity Gaming” (https://www.nnw.fm/kREPi). Pearce, a data-driven, strategic brand marketer with more than 15 years of proven success in the global gaming industry, focused the article on the growing exposure and popularity of eSports in the wake of COVID-19 and the resulting forced closure of traditional sports. In the piece, Pearce indicated that there will be 2.7 billion gamers worldwide with 2.5 billion playing on mobile, 1.3 billion on PC and 0.8 billion on console by the end of this year. The…

Continue Reading

TuesdaySep 22, 2020 1:34 pm

NetworkNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Plans for Name Change, Another Step in Building Strong Brand

Grey Cloak Tech (OTC: GRCK), engaged in proprietary development of natural plant-based formulations, sales and distribution of cardiovascular and neuro products, today announced that it has filed a Schedule 14C to notify shareholders of a name change to Healthy Extracts Inc. According to the update, the name change is part of the company’s corporate strategy that aligns science-based, proprietary exclusive products and intellectual properties (“IPs”) and better reflects its focus. The trading symbol will also change to one yet to be determined. “We are excited to announce the filing of our name change from Grey Cloak Tech to Healthy Extracts…

Continue Reading

TuesdaySep 22, 2020 12:45 pm

NetworkNewsBreaks – InvestorBrandNetwork Podcast Series Tops 400 Total Episodes

InvestorBrandNetwork (“IBN”), an innovative corporate communications agency and diversified content distributor, has now released more than 400 unique podcast episodes through the IBN Podcast Series. Episodes are published on multiple syndicated platforms, including Apple Podcasts, Google Podcasts, iHeartRadio, Spotify, Stitcher, TuneIn, Bullhorn and others. IBN serves more than 500 clients through its unique interconnected network, which includes 50-plus brands. Each brand focuses on a specific market segment. In addition to that network, IBN works with more than 5,000 syndication partners and 50-plus event partners to provide the widest dissemination of news and information possible. Currently, IBN is delivering on a series of…

Continue Reading

TuesdaySep 22, 2020 12:31 pm

NetworkNewsBreaks – IDEAYA Biosciences Inc. (NASDAQ: IDYA) Announces ‘Transformational’ Second Quarter

IDEAYA Biosciences (NASDAQ: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics, recently provided a business update and announced financial results for the second quarter ended June 30, 2020. "This quarter was transformational for IDEAYA. We have cash runway into 2024, with quarter-end cash, cash equivalents and marketable securities of $172.0 million supplemented by $127.5 million aggregate gross proceeds received subsequently, including $100 million non-dilutive upfront cash and $20 million private placement equity investment from GSK,” said Yujiro S. Hata, CEO and president of IDEAYA Biosciences, in the press release. “In addition, through our…

Continue Reading

TuesdaySep 22, 2020 12:12 pm

NetworkNewsBreaks – CB Scientific Inc. (CBSC) Completes Asset Purchase Agreement, Focuses on ECG Monitoring Business

CB Scientific (OTC: CBSC), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, has completed the acquisition of Prevent Health Care International Corp., a private company located in British Columbia. The acquisition included PHCIC’s medical technology products developed to date, intellectual property, manufacturing expertise and patents. CB Scientific also acquired all information and knowledge available to promote, market and sell PHCIC’s product worldwide, excluding Australia. In addition, CBSC has acquired the subsidiaries of PHCIC, including My-Cardia USA Inc. and related businesses. Following the acquisition, CBSC assembled a core management team to continue the operation of…

Continue Reading

TuesdaySep 22, 2020 11:56 am

NetworkNewsBreaks – InvestorBrandNetwork Announces New Stock2Me Podcast Episode Featuring Renowned Expert on Sales, Negotiation and Raising Capital – Oren Klaff

InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, today announced the release of the latest Stock2Me Podcast featuring Oren Klaff, a bestselling author, speaker and director of Capital Markets at Intersection Capital. Klaff has extensively studied human-to-human response in high-stakes business situations and pioneered the application of neuroscience into raising capital and capital markets programs. His first book, “Pitch Anything,” has amassed more than 1 million copies in print worldwide and become compulsory reading on Wall Street and throughout Silicon Valley and the Fortune 500. During The Stock2Me Podcast episode, hosted by IBN’s…

Continue Reading

TuesdaySep 22, 2020 11:19 am

NetworkNewsBreaks – Sanwire Corp. (SNWR) Launches Updated Software Platform, Website Through Subsidiary

Sanwire Corp. (SNWR) and its wholly owned subsidiary Intercept Music Inc. has announced the release of version 2.0 of its software platform and website. This updated platform is designed to enhance the experience of Intercept Music’s clients as well as drive additional revenues, both for Intercept and its clients. Updates to the platform allow artists to see where their music is streamed and downloaded as well as identify the service used for that stream or download. Artists can also assess the impact of their marketing efforts for all social media platforms on a single dashboard. The enhanced dashboard shows how…

Continue Reading

TuesdaySep 22, 2020 11:07 am

NetworkNewsBreaks – Cannabis Global Inc. (CBGL), NPE Collaborate on Multiple Levels Following Strategic Investment

Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today provided shareholders with more details following the company's recent 18.8% strategic investment stake in Natural Plant Extract (“NPE”). Operating out of Lynwood, California, NPE holds a Type 7 California manufacturing and distribution license, allowing for cannabis product distribution anywhere in the state. Through the newly formed strategic relationship, Cannabis Global and NPE management teams are already collaborating on multiple levels, including the integration of several of the company's technologies in products manufactured by NPE and distributed by NPE's Northern Lights Distribution. "Aside from…

Continue Reading